Emerging market opportunities include advanced therapies for RSV, COVID-19, UTIs, HIV, and fungal infections, with promising candidates such as Moderna's mRNA assets, GSK's TBP-PI-HBr, and Armata's AP ...
At Ignite, Microsoft said software is 'evolving from being made for people to being made by people.' Attendees I spoke with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback